BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21166665)

  • 21. Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells.
    Lueder Y; Heller K; Ritter C; Keyser KA; Wagner K; Liu X; Messerle M; Stahl FR; Halle S; Förster R
    PLoS Pathog; 2018 Aug; 14(8):e1007252. PubMed ID: 30153311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wiskott-Aldrich syndrome protein may be critical for CD8
    Li S; Huang J; Zhang YL; Zhu Y; An YF; Du J; Zhang ZL; Xia Y; Liu L; Wang L; Luo XH
    Cell Immunol; 2019 Apr; 338():43-50. PubMed ID: 30981413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
    Nomura M; Kurita-Taniguchi M; Kondo K; Inoue N; Matsumoto M; Yamanishi K; Okabe M; Seya T
    Eur J Immunol; 2002 Oct; 32(10):2954-64. PubMed ID: 12355449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
    Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
    J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.
    Bantug GR; Cekinovic D; Bradford R; Koontz T; Jonjic S; Britt WJ
    J Immunol; 2008 Aug; 181(3):2111-23. PubMed ID: 18641350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the Dynamics of MCMV-Specific CD8
    Gabel M; Baumann NS; Oxenius A; Graw F
    Front Immunol; 2019; 10():1358. PubMed ID: 31281313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of virus-induced interferon-gamma responses in mice previously infected with murine cytomegalovirus.
    Shanley JD; Shanley JA; Albert G; Biegel D
    J Infect Dis; 2001 Mar; 183(5):697-706. PubMed ID: 11181145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology.
    Santos NB; Vaz da Silva ZE; Gomes C; Reis CA; Amorim MJ
    PLoS Pathog; 2021 Jul; 17(7):e1009381. PubMed ID: 34197564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
    Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
    J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
    Gopal IN; Quinn A; Henry SC; Hamilton JD; Staats HF; Frothingham R
    Microbiol Immunol; 2005; 49(2):113-9. PubMed ID: 15722596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma.
    Cheeran MC; Gekker G; Hu S; Palmquist JM; Lokensgard JR
    J Neurovirol; 2005 Jul; 11(3):274-80. PubMed ID: 16036807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
    Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
    J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.
    Tay CH; Welsh RM
    J Virol; 1997 Jan; 71(1):267-75. PubMed ID: 8985346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.
    Oakley OR; Garvy BA; Humphreys S; Qureshi MH; Pomeroy C
    Clin Exp Immunol; 2008 Jan; 151(1):155-64. PubMed ID: 18005264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
    Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.
    Simon CO; Holtappels R; Tervo HM; Böhm V; Däubner T; Oehrlein-Karpi SA; Kühnapfel B; Renzaho A; Strand D; Podlech J; Reddehase MJ; Grzimek NK
    J Virol; 2006 Nov; 80(21):10436-56. PubMed ID: 16928768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus.
    Tanaka K; Sawamura S; Satoh T; Kobayashi K; Noda S
    J Immunol; 2007 Apr; 178(8):5209-16. PubMed ID: 17404304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.